The breast cancer risk assessment test that detected Olivia Munn's aggressive Luminal B cancer has now identified breast ...

Scientists have discovered a protein that acts like a “suit of armour” for skin cancer cells in a breakthrough that could ...

Researchers discovered how to flip the structure of complex drug compounds using a simple reagent, offering a game-changing ...

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

Landmark research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some promising cancer treatments are causing serious side effects, and offers ...

Cancer cells can acquire energy-generating structures called mitochondria from nearby nerve cells, which seems to aid their ...

We also found that tumors release a protein called Activin-A, which acts on blood vessels to cause the leakiness and, ultimately, loss of blood vessels in the muscle. When we used a gene therapy to ...

Mary Beckerle is stepping down from her long tenure as CEO of Huntsman Cancer Institute at the University of Utah. Beckerle ...

The researchers engineered a compound that kills leukemia cells with potency comparable to FDA-approved therapies by ...

The study, published in the journal Cancer Discovery, analyzed over 2 million cases and found significant increases in early-onset cancers.